Brief: Sangamo Therapeutics Announces FDA Acceptance Of BLA Rolling Submission Request
21/11/2025 13:36
Nov 21 (Reuters) - Sangamo Therapeutics Inc SGMO.O: SANGAMO THERAPEUTICS ANNOUNCES FDA ACCEPTANCE OF BLA ROLLING SUBMISSION REQUEST FOR ST-920 IN FABRY DISEASE SANGAMO THERAPEUTICS INC - TO INITIATE ROLLING SUBMISSION OF BLA IN Q4 2025 Source text: ID:nGNX1fsHjj Further company coverage: SGMO.O ((Reuters.Briefs@thomsonreuters.com;))